Atlas Trials

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Clinical trial NCT06130683 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06130683
Sponsor
China-Japan Friendship Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Secondary Hyperparathyroidism
Start date
2023-11-10
Primary completion
2024-12-08
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.